Target intelligence / Profile preview

Necrotic and denatured extracellular matrix and wound debris proteins

Molecular classification
Extracellular matrix protein, Proteinaceous debris
01

Overview

Necrotic and denatured extracellular matrix and wound debris proteins represent the non-viable proteinaceous material that accumulates in chronic and acute wounds. This material, often referred to as eschar or slough, consists of denatured collagen, fibrin, and other cellular remnants that have lost their biological function due to ischemia, infection, or trauma (StatPearls, Wound Debridement, 2023). In the context of wound healing, these proteins act as a physical barrier to re-epithelialization and provide a niche for bacterial colonization and biofilm formation (Wound Repair and Regeneration, 2013). Therapeutic intervention focuses on enzymatic debridement, where exogenous proteases are applied to selectively digest these denatured proteins without harming healthy tissue. By removing this debris, the wound environment is optimized for granulation tissue formation and subsequent closure (Journal of Wound Care, 2019). Common agents targeting this substrate include collagenase and bromelain-based concentrates, which break down the structural integrity of the necrotic mass (FDA, Santyl Prescribing Information; EMA, NexoBrid Summary of Product Characteristics).

Other names
Necrotic tissueEscharSloughDevitalized tissueDenatured extracellular matrixWound debrisNon-viable tissue
02

Mechanism of action

Enzymatic proteolysis and digestion of denatured extracellular matrix components and necrotic debris to facilitate wound bed preparation and promote healing.

03

Biological functions

Structural supportInflammatory stimulusBacterial substrate
04

Disease associations

Chronic woundBurnPressure ulcerDiabetic foot ulcerVenous leg ulcer
05

Safety considerations

Proteolysis of healthy viable tissueLocal irritationHypersensitivity reactionsPain at application site
06

Interacting drugs

Collagenase clostridium histolyticum

5 more in the full profile.

07

Biomarkers

Wound bed scorePercentage of necrotic tissuePresence of escharSlough volume

Beyond the preview

Go deeper on Necrotic and denatured extracellular matrix and wound debris proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Necrotic and denatured extracellular matrix and wound debris proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call